您当前的位置:

Simotinib

目录号: PL01293 纯度: ≥99%
Simotinib 是一种选择性、特异性、口服生物利用度高的 EGFR 酪氨酸激酶抑制剂,IC50 为 19.9 nM。抗肿瘤活性。
CAS No. :944258-89-3
商品编号 规格 价格 会员价 是否有货 数量
PL01293-5mg 5mg ¥5625.00 请登录
PL01293-10mg 10mg ¥9322.00 请登录
PL01293-25mg 25mg ¥17680.00 请登录
PL01293-50mg 50mg 询价 询价
PL01293-100mg 100mg 询价 询价
PL01293-10mM*1mLinDMSO 10mM*1mLinDMSO ¥6188.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
Simotinib
英文名称
Simotinib
英文别名
Simotinib;58K797D5IK;SIM6802;GTPL7640;SIM 6802;AL6802;AL 6802;Q27088802
Cas No.
944258-89-3
分子式
C25H26ClFN4O4
分子量
500.95
包装储存
Powder -20°C 3 years;4°C 2 years
详情描述
Simotinib 是一种选择性、特异性、口服生物利用度高的 EGFR 酪氨酸激酶抑制剂,IC50 为 19.9 nM。抗肿瘤活性。
产品详情
Simotinib 是一种选择性、特异性、口服生物利用度高的 EGFR 酪氨酸激酶抑制剂,IC50 为 19.9 nM。抗肿瘤活性。
生物活性
Simotinib is a selective, specific, and orally bioavailable EGFR tyrosine kinase inhibitor, with an IC 50 of 19.9 nM. Antineoplastic activities.
性状
Solid
IC50 & Target[1][2]
EGFR 19.9 nM (IC50)
体外研究(In Vitro)
Simotinib inhibits in a dose-dependent manner EGFR and the growth of human A431 tumor cells with high expression of EGFR, with no significant activity on other investigated kinases. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Simotinib has been shown to exert its antitumor activity by inhibiting EGFR phosphorylation in nude xenograft model. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
ClinicalTrial
参考文献
[1]. Hu XS, et al. Safety, tolerability, and pharmacokinetics of simotinib, a novel specific EGFR tyrosine kinase inhibitor, in patients with advanced non-small cell lung cancer: results of a phase Ib trial. Cancer Manag Res. 2019;11:4449-4459. Published 2019
溶解度数据
In Vitro: DMSO : 125 mg/mL (249.53 mM; ultrasonic and adjust pH to 3 with HCl)配制储备液
搜索质检报告(COA)
[1]. Hu XS, et al. Safety, tolerability, and pharmacokinetics of simotinib, a novel specific EGFR tyrosine kinase inhibitor, in patients with advanced non-small cell lung cancer: results of a phase Ib trial. Cancer Manag Res. 2019;11:4449-4459. Published 2019

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

相关产品

更多
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2